FDA advisors back Novavax COVID-19 vaccine as a new U.S. option
2 years, 6 months ago

FDA advisors back Novavax COVID-19 vaccine as a new U.S. option

LA Times  

American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisors to the Food and Drug Administration on Tuesday backed a more traditional type of shot. Next, the FDA must decide whether to authorize the vaccine made by latecomer Novavax, a protein vaccine that’s made with a more conventional tech- nology than today’s U.S. options. FDA’s vaccine chief Dr. Peter Marks said another choice in the U.S. may entice at least some vaccine holdouts — whatever their reason — to consider rolling up their sleeves. “Anything we can do to get people more comfortable to accept these potentially lifesaving products is something that we feel we are compelled to do.” If the FDA authorizes Novavax as the nation’s fourth vaccine, it’s not clear how widely it would be used — at least right away. Novavax, a small biotech company, created the vaccine in its research lab, but the Serum Institute of India, the world’s largest vaccine maker, produces most of its shots including those slated for the U.S.

Fda Vaccine Novavax Heart Inflammation  used  inflammation  company  vaccines  vaccine  fda  immune  option  protein  shots  novavax  advisors  covid19

History of this topic

FDA approves updated COVID-19 vaccines; shots should be available in days
4 months ago

FDA approves updated COVID-19 vaccines; shots should be available in days

LA Times  

With the Food and Drug Administration’s clearance, Pfizer and Moderna are set to begin shipping millions of doses of the new COVID019 vaccine. U.S. regulators approved updated COVID-19 vaccines on Thursday, shots designed to more closely target recent virus strains — and hopefully whatever variants cause trouble this winter too. “We strongly encourage those who are eligible to consider receiving …

Novavax’s COVID-19 vaccine gets the green light from the FDA, giving third option for protection
1 year, 2 months ago

Novavax’s COVID-19 vaccine gets the green light from the FDA, giving third option for protection

Salon  

On Tuesday, the Food and Drug Administration authorized the use of a new Novavax vaccine specifically targeted to protect against the latest Omicron circulating strains. Following a bumpy rollout of the Moderna and Pfizer vaccines, it will bring another option to the table for those who are ready to roll up their sleeves and get vaccinated amid a rise in …

Updated COVID vaccines will be available later this week, recommended for everyone six months and up
1 year, 3 months ago

Updated COVID vaccines will be available later this week, recommended for everyone six months and up

Salon  

A new, fourth round of COVID-19 booster shots was approved Tuesday, following the recommendation of federal health agencies, which will make the vaccines available to Americans later this week. The Centers for Disease Control and Prevention followed suit this afternoon, with CDC director Mandy Cohen recommending updated vaccination for "everyone 6 months and older to better protect you and your …

Should you get the new COVID booster? The CDC is about to decide
1 year, 3 months ago

Should you get the new COVID booster? The CDC is about to decide

LA Times  

A nurse prepares a syringe of a COVID-19 vaccine. The CDC’s vaccine advisors will soon decide whether to recommend the latest COVID-19 boosters only for frail, older, sick and immunocompromised people or to offer it to everyone over 6 months of age. “I don’t plan to get it myself,” said Dr. Paul Offit, the director of the Vaccine Education Center …

COVID-19 vaccine maker Novavax to chop workforce, expenses
1 year, 7 months ago

COVID-19 vaccine maker Novavax to chop workforce, expenses

Associated Press  

Novavax is cutting about a quarter of its global workforce as the COVID-19 vaccine maker seeks to slash expenses while dealing with uncertain future revenue. The company said Tuesday that it expects to trim next year’s costs for research and development as well as selling, general and administrative expenses by about 40% to 50% compared to 2022. A Novavax representative …

CDC signs off on additional Covid-19 booster doses for certain people
1 year, 8 months ago

CDC signs off on additional Covid-19 booster doses for certain people

CNN  

CNN — The US Centers for Disease Control and Prevention updated its recommendations on the Covid-19 vaccines on Wednesday to allow another dose of the bivalent booster for people who are 65 and older or who have weakened immune systems and who “want the option of added protection” against the coronavirus. The move aligns with Tuesday’s US Food and Drug …

FDA’s advisors back plan to simplify COVID-19 vaccinations
1 year, 10 months ago

FDA’s advisors back plan to simplify COVID-19 vaccinations

LA Times  

Syringes with COVDI-19 vaccines are prepared at a free public clinic in Lynwood last year. “We’re still protected against severe disease, thank goodness,” even after the latest Omicron strains cropped up, said FDA advisor Dr. Paul Offit, a vaccine expert at Children’s Hospital of Philadelphia. The first step: The FDA advisory panel voted unanimously that people should get the same …

FDA proposes once-a-year COVID-19 shots for most Americans
1 year, 11 months ago

FDA proposes once-a-year COVID-19 shots for most Americans

LA Times  

U.S. health officials are proposing a simplified approach to COVID-19 vaccinations for most adults and children. That baseline of protection should be enough to move to an annual booster against the latest strains in circulation and make COVID-19 vaccinations more like the yearly flu shot, according to the agency. FDA scientists and vaccine companies would study vaccination, infection rates and …

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose
1 year, 11 months ago

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose

News 18  

The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said on Monday. Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India, had recently written to the DCGI for the approval …

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose
2 years ago

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose

News 18  

The Serum Institute of India has sought the drug regulator’s approval for market authorisation of its COVID-19 vaccine Covovax as a booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin, official sources said on Thursday. Prakash Kumar Singh, director, government and regulatory affairs, SII, submitted a market authorisation application for …

As COVID-19 spikes in California, booster shots could make all the difference
2 years ago

As COVID-19 spikes in California, booster shots could make all the difference

LA Times  

With coronavirus cases and hospitalizations rising in Los Angeles County, officials are voicing new confidence in the effectiveness of the updated COVID-19 booster shot. New data has found that the updated COVID-19 vaccines offer “significant additional protection” against symptomatic infection in people who were previously vaccinated or boosted with the older formula. “We have seen very low uptake of the …

U.S. clears Novavax vaccine for use as COVID-19 booster
2 years, 2 months ago

U.S. clears Novavax vaccine for use as COVID-19 booster

LA Times  

A vial of the COVID-19 vaccine made by Novavax. U.S. regulators on Wednesday authorized a booster dose of the COVID-19 vaccine made by Novavax. The Food and Drug Administration said the new booster option is for people 18 and older who can’t get the Omicron-targeting boosters from Pfizer-BioNTech or Moderna for medical or accessibility reasons — or who otherwise would …

CDC endorses more traditional Novavax COVID shot for adults
2 years, 5 months ago

CDC endorses more traditional Novavax COVID shot for adults

Associated Press  

U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax -- a more traditional kind of vaccine, health officials said Tuesday. THE NOVAVAX DIFFERENCE All of the vaccines used in the U.S. train the body to fight the coronavirus by recognizing its outer coating, the spike protein -- and the first three options essentially …

CDC endorses more traditional Novavax COVID-19 shot
2 years, 5 months ago

CDC endorses more traditional Novavax COVID-19 shot

LA Times  

A dish with syringes containing the Novavax COVID-19 vaccine sits in a refrigerator ready for use. U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax — a more traditional kind of vaccine, health officials said Tuesday. The Novavax difference All of the vaccines used in the U.S. train the body to fight the …

The CDC endorses Novavax, a more traditional COVID vaccine, for adults
2 years, 5 months ago

The CDC endorses Novavax, a more traditional COVID vaccine, for adults

NPR  

The CDC endorses Novavax, a more traditional COVID vaccine, for adults Enlarge this image toggle caption Georg Wendt/AP Georg Wendt/AP U.S. adults who haven't gotten any COVID-19 shots yet should consider a new option from Novavax — a more traditional kind of vaccine, health officials said Tuesday. The Novavax difference All of the vaccines used in the U.S. train the …

US regulators OK new COVID-19 shot option from Novavax
2 years, 5 months ago

US regulators OK new COVID-19 shot option from Novavax

Associated Press  

The U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared Novavax shots for adults. Novavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S. -- and one that’s already available in Europe and multiple other countries. Novavax also has submitted data on booster …

COVID-19: US FDA authorises Novavax vaccine for emergency use in adults
2 years, 5 months ago

COVID-19: US FDA authorises Novavax vaccine for emergency use in adults

India TV News  

Highlights US regulators OK new COVID-19 shot option from Novavax vaccine Food and Drug Administration on Wednesday cleared Novavax shots for adults in US Novavax makes more traditional type of shot than three other COVID vaccines available for use in US COVID-19 news : The US is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday …

Will Americans have the right COVID-19 vaccine this fall? Maybe
2 years, 5 months ago

Will Americans have the right COVID-19 vaccine this fall? Maybe

LA Times  

A man walks underneath the marquee of the Alex Theatre in Glendale. Determining which recipe should go into those doses to induce optimal protection — the vaccine’s “composition” — is an exercise in educated guesswork. Getting a timely and accurate fix on all this “is truly a challenge, and it is science at its hardest,” Dr. Peter Marks, the U.S. …

Multipronged vaccine protects against COVID virus family members — even some still in hiding
2 years, 5 months ago

Multipronged vaccine protects against COVID virus family members — even some still in hiding

LA Times  

Researchers at Caltech have devised an experimental vaccine that targets an array of coronaviruses and variants in a single shot. “We’ve had three pandemics or epidemics in the past 20 years: first SARS, then MERS, then SARS-CoV-2,” said Caltech biochemist Pamela Bjorkman, who led the new work. More outbreaks sparked by “spillover events” are inevitable, she said, and “we want …

FDA advisers recommend updating COVID booster shots for fall
2 years, 5 months ago

FDA advisers recommend updating COVID booster shots for fall

Associated Press  

At least some U.S. adults may get updated COVID-19 shots this fall, as government advisers voted Tuesday that it’s time to tweak booster doses to better match the most recent virus variants. Their combination shots, what scientists call “bivalent” vaccines, substantially boosted levels of antibodies capable of fighting that variant, more than simply giving another dose of today’s vaccine. Marks …

FDA advisors recommend updating COVID booster shot formula for fall
2 years, 5 months ago

FDA advisors recommend updating COVID booster shot formula for fall

LA Times  

Advisors to the Food and Drug Administration are recommending that some U.S. adults get a modified COVID-19 booster shot this fall that better matches the recent variants. Some U.S. adults are a step closer to getting updated COVID-19 boosters this fall, as government advisors voted Tuesday that it’s time to tweak the shots to better match the most recent virus …

The Most Common Questions About The Novavax COVID Vaccine, Answered
2 years, 6 months ago

The Most Common Questions About The Novavax COVID Vaccine, Answered

Huff Post  

LOADING ERROR LOADING As scientists and health experts continue to learn how to fight the virus, more treatment and prevention methods are becoming available ― including additional vaccines. Novavax’s COVID-19 shot “is a technology commonly used in most other vaccines, such as flu, hepatitis B and shingles,” said Dr. Mahdee Sobhanie, an infectious diseases physician at Ohio State University Wexner …

New COVID-19 vaccine may be option for troops with religious concerns
2 years, 6 months ago

New COVID-19 vaccine may be option for troops with religious concerns

LA Times  

A vial of the the Novavax COVID-19 vaccine is readied for use. A COVID-19 vaccine that could soon win federal authorization may offer a boost for the U.S. military: an opportunity to get shots into some of the thousands of service members who have refused other COVID-19 vaccines for religious reasons. One group involved in lawsuits targeting the military’s vaccine …

FDA advisers back Novavax COVID-19 shots as fourth US option
2 years, 6 months ago

FDA advisers back Novavax COVID-19 shots as fourth US option

Firstpost  

The FDA advisory panel voted that the benefits of two primary Novavax doses outweigh its risks — but they had a lot of questions about the shots’ role at this point in the pandemic. Next, the FDA must decide whether to authorize the protein vaccine made by latecomer Novavax as the nation’s fourth coronavirus shot for adults. FDA’s vaccine chief …

FDA advisers back Novavax COVID shots as 4th US option
2 years, 6 months ago

FDA advisers back Novavax COVID shots as 4th US option

Associated Press  

American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot. Next, the FDA must decide whether to authorize the protein vaccine made by latecomer Novavax as the nation’s fourth coronavirus shot for adults. FDA’s vaccine chief Dr. Peter Marks …

FDA advisory panel gives near-unanimous recommendation to Novavax's COVID-19 vaccine
2 years, 6 months ago

FDA advisory panel gives near-unanimous recommendation to Novavax's COVID-19 vaccine

Daily Mail  

Novavax's COVID-19 vaccine received near-unanimous approval for use in adults over 18 years old on Tuesday, paving the way for it to become the fourth jab and first protein-based shot to be rolled out in America. Unlike Pfizer and Moderna's shots, the Novavax jab uses the same protein-based technology as flu vaccines, which expose the immune system to spike proteins …

Advisers to the FDA back Novavax COVID vaccine
2 years, 6 months ago

Advisers to the FDA back Novavax COVID vaccine

NPR  

Advisers to the FDA back Novavax COVID vaccine Enlarge this image toggle caption Karen Ducey/Getty Images Karen Ducey/Getty Images In a 21-0 vote with one abstention, advisers to the Food and Drug Administration recommended that the agency authorize Novavax's two-dose vaccine against COVID-19. In comments to the committee before its vote, Dr. Peter Marks, the FDA's top vaccine official said, …

Novavax hopes its COVID shot wins over FDA, vaccine holdouts
2 years, 6 months ago

Novavax hopes its COVID shot wins over FDA, vaccine holdouts

Associated Press  

— Americans may soon get a new COVID-19 vaccine option -- shots made with a more tried-and-true technology than today’s versions. “What I’ve seen of the Novavax data so far is it’s a really impressive protein vaccine,” said University of Pennsylvania immunologist E. John Wherry. Novavax, a small biotech company, created the vaccine in its research lab, but the Serum …

Q&A: Novavax hopes its COVID shot wins over FDA, vaccine holdouts
2 years, 6 months ago

Q&A: Novavax hopes its COVID shot wins over FDA, vaccine holdouts

LA Times  

Americans may soon get a new COVID-19 vaccine option — shots made with a more tried-and-true technology than today’s versions. “What I’ve seen of the Novavax data so far is it’s a really impressive protein vaccine,” said University of Pennsylvania immunologist E. John Wherry. Novavax, a small biotech company, created the vaccine in its research lab, but the Serum Institute …

With old-school technology, can Novavax win over COVID vaccine skeptics?
2 years, 7 months ago

With old-school technology, can Novavax win over COVID vaccine skeptics?

LA Times  

A vial of the Novavax COVID-19 vaccine is ready for use in a Phase 3 clinical trial in London. Some people “may prefer tried and true technologies” for COVID-19 vaccines, said Dr. Filip Dubovsky, the chief medical officer of Novavax. It’s even possible a single Novavax shot could target multiple coronavirus variants in one shot, although Dubovsky said it makes …

Dutch gov’t ordered 840,000 Novavax Covid jabs; Only 1,000 shots used
2 years, 8 months ago

Dutch gov’t ordered 840,000 Novavax Covid jabs; Only 1,000 shots used

NL Times  

The Netherlands purchased 840,000 doses of the Novavax vaccine against Covid-19 for approximately 15 million euros, but nobody seems to want the protein-based vaccine. The government purchased the Novavax vaccines as an alternative for people who don't want to get an mRNA vaccine or vector vaccine against the coronavirus because the techniques behind those are still young. But since March …

ATAGI is recommending a fourth COVID-19 vaccine for some Australians. Here's what you need to know
2 years, 9 months ago

ATAGI is recommending a fourth COVID-19 vaccine for some Australians. Here's what you need to know

ABC  

Australians aged 65+ and other vulnerable individuals are set to begin rolling up their sleeves for another COVID-19 vaccine dose in just a couple of weeks. In a bid to increase vaccine protection ahead of winter, the nation's top vaccine advisory group has recommended an additional booster dose for those who are at greatest risk of severe illness from COVID-19. …

Rich countries getting new COVID vaccine before poorer ones despite U.N.-backed initiative
2 years, 9 months ago

Rich countries getting new COVID vaccine before poorer ones despite U.N.-backed initiative

LA Times  

A worker moves boxes carrying Novavax’s COVID-19 vaccine at SK Bioscience Co. in Andong, South Korea, on Feb. 9. Novavax, the company behind a COVID-19 vaccine touted as a key tool for the developing world, will miss a target for giving doses to a U.N.-backed effort to supply shots to poorer countries. The company behind a COVID-19 vaccine touted as …

Rich Countries Getting New COVID Vaccine Before Poorer Ones
2 years, 9 months ago

Rich Countries Getting New COVID Vaccine Before Poorer Ones

Huff Post  

FILE - A worker moves boxes carrying Novavax's COVID-19 vaccine at SK Bioscience Co. in Andong, South Korea, on Feb. 9, 2022. via Associated Press NEW DELHI — The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the U.N.-backed …

Rich countries getting new COVID vaccine before poorer ones
2 years, 9 months ago

Rich countries getting new COVID vaccine before poorer ones

Associated Press  

NEW DELHI — The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the U.N.-backed effort to supply poorer countries, a sign that inequity persists in the global response to the pandemic. The company, Novavax, got $388 million from one …

Rich countries getting new Novavax COVID-19 vaccine before poorer ones
2 years, 9 months ago

Rich countries getting new Novavax COVID-19 vaccine before poorer ones

LA Times  

The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the United Nations-backed effort to supply poorer countries, a sign that inequity persists in the global response to the pandemic. The investment guaranteed COVAX the “right of first refusal” to …

Better to err on the side of caution to ensure public health during pandemic, TN tells SC
2 years, 9 months ago

Better to err on the side of caution to ensure public health during pandemic, TN tells SC

The Hindu  

States like Tamil Nadu and Maharashtra in the Supreme Court on Tuesday justified their hardened stand to make COVID-19 inoculation mandatory, even at the cost of denying people their rights, by saying that it was better to err on the side of caution to prevent serious or irreversible harm to the public when there was insufficient information about the virus. …

Second COVID booster shot does little to stop Omicron, study finds
2 years, 9 months ago

Second COVID booster shot does little to stop Omicron, study finds

LA Times  

Dr. Jacov Lavee receives a fourth dose of the Comirnaty vaccine in Ramat Gan, Israel, as part of a trial to test whether a second COVID-19 booster shot helps protect against infection and illness. Compared to getting two initial doses and one booster shot of Pfizer and BioNTech’s Comirnaty vaccine, adding a second booster shot reduced the rate of coronavirus …

COVID: New protein-based vaccine up for approval
2 years, 10 months ago

COVID: New protein-based vaccine up for approval

The Hindu  

Sanofi and GlaxoSmithKline are seeking E.U. and U.S. regulatory approval of their protein-based COVID-19 vaccine, which proved 100 per cent effective at preventing severe illness in phase three clinical trials, the duo announced on Wednesday. Official trial results are yet to be published, but the companies reported that in phase three testing, two doses of the vaccine showed 100 per …

Novavax says protein vaccine works for kids as young as 12
2 years, 10 months ago

Novavax says protein vaccine works for kids as young as 12

India Today  

Novavax announced Thursday that its Covid-19 vaccine proved safe and effective in a study of 12- to 17-year-olds. Novavax makes a protein-based vaccine -- a different type than the most widely used shots -- that’s a late arrival to the Covid-19 arsenal. The latest study enrolled 2,247 US kids ages 12 to 17 last summer and found the two-dose vaccine …

COVID-19 pandemic: Novavax says protein vaccine works for kids as young as 12
2 years, 10 months ago

COVID-19 pandemic: Novavax says protein vaccine works for kids as young as 12

India TV News  

Highlights On Feb 10, Novavax announced that its COVID vaccine proved safe, effective in study of 12-17 yr olds Novavax makes a protein-based vaccine- a different type than the most widely used shots Novavax plans to soon seek expanded use of its shots down to age 12 Novavax announced on Thursday that its COVID-19 vaccine proved safe and effective in …

COVID pills, a holy grail vaccine and 'immune fitness': Why there's a virus 'recalibration' coming
2 years, 10 months ago

COVID pills, a holy grail vaccine and 'immune fitness': Why there's a virus 'recalibration' coming

ABC  

Kerry Chant probably summed it up best: "All of us just want COVID to be gone." This means people should focus more on their "immune fitness" this year, Professor Jenkins says. Novavax is a "protein subunit" vaccine which means it introduces a part of the COVID virus to the immune system but it doesn't contain any live components of the …

Over 52,000 children under 12 have received a Covid jab; Novavax ready in March
2 years, 10 months ago

Over 52,000 children under 12 have received a Covid jab; Novavax ready in March

NL Times  

In recent weeks, 52,047 children under the age of 12 have received a shot to protect them against Covid-19. Some 351 children aged 5 to 11 have even received their second shot, with which they are considered to be fully vaccinated. Children under 12 receive two shots of a smaller dose of the vaccine from Pfizer and BioNTech than people …

Novavax becomes Australia's 5th approved Covid-19 vaccine
2 years, 11 months ago

Novavax becomes Australia's 5th approved Covid-19 vaccine

India Today  

Novavax's Covid-19 vaccine on Thursday became the fifth coronavirus vaccine approved for use in Australia. The Novavax vaccine will be available to unvaccinated Australians aged 18 years and older but will not be used as a booster for the 95 per cent of the population aged 16 and older who have already received a vaccine. "There are some individuals, notwithstanding …

Novavax becomes Australia\'s 5th approved COVID-19 vaccine
2 years, 11 months ago

Novavax becomes Australia\'s 5th approved COVID-19 vaccine

Deccan Chronicle  

Canberra: Novavax's COVID-19 vaccine on Thursday became the fifth coronavirus vaccine approved for use in Australia. “There are some individuals, notwithstanding a massive take up of vaccination in this country, who have been waiting for Novavax, and it's great that it's finally been approved,” said chief regulator John Skerritt, head of the Therapeutic Goods Administration. Paul Griffin, associate professor of …

Dutch health council backs Novavax for people who object to mRNA vaccines
3 years ago

Dutch health council backs Novavax for people who object to mRNA vaccines

Dutch News  

The Dutch health council is recommending that people who have not yet been vaccinated against coronavirus but have a principle objection to the types currently on offer be given the option of the new Novavax vaccine. The Gezondheidsraad said that it still recommended the Pfizer Biontech and Moderna vaccines above other brands but said that the Novavax vaccine was suitable …

Dutch health council backs Novavax for people who object to mRNA vaccines
3 years ago

Dutch health council backs Novavax for people who object to mRNA vaccines

Dutch News  

The Dutch health council is recommending that people who have not yet been vaccinated against coronavirus but have a principle objection to the types currently on offer be given the option of the new Novavax vaccine. The Gezondheidsraad said that it still recommended the Pfizer Biontech and Moderna vaccines above other brands but said that the Novavax vaccine was suitable …

Novavax Covid vaccine could win Dutch approval Friday as mRNA alternative
3 years ago

Novavax Covid vaccine could win Dutch approval Friday as mRNA alternative

NL Times  

Adults who have not yet been vaccinated against Covid-19 and who object to using vaccines based on newer mRNA techniques should be given the opportunity to opt for the new vaccine from Novavax, the Dutch Health Council recommended. The advisory note sent from the Council to Health Minister Hugo de Jonge gave a positive recommendation to use the Novavax vaccine, …

WHO clears Novavax as 10th authorised COVID-19 jab: From efficacy to side-effects, all you need to know about vaccine
3 years ago

WHO clears Novavax as 10th authorised COVID-19 jab: From efficacy to side-effects, all you need to know about vaccine

Firstpost  

Nuvaxovid, made from a more conventional technology than others already approved, is likely to help persuade those hesitant about vaccination to come forward On Tuesday, the World Health Organization approved a COVID-19 vaccine made by United States pharma giant Novavax for emergency use, after the European Union medicines regulator gave it the green light. As Dery explains : “For vaccine …

Discover Related